brimonidine tartrate has been researched along with Dermatitis Medicamentosa in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, TT; Werner, K | 1 |
| Aires, D; Fischer, R; Gillihan, R; Nguyen, T; Rajpara, A | 1 |
| Rajagopalan, A; Rajagopalan, B | 1 |
| Gerber, PA | 1 |
| Brodsky, MC; Scruggs, JT; Whiteside-Michel, J | 1 |
5 other study(ies) available for brimonidine tartrate and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Dermatitis medicamentosa: severe rebound erythema secondary to topical brimonidine in rosacea.
Topics: Adult; Brimonidine Tartrate; Dermatologic Agents; Drug Eruptions; Erythema; Female; Humans; Rosacea | 2015 |
Erythema in Skin Adjacent to Area of Long-term Brimonidine Treatment for Rosacea: A Novel Adverse Reaction.
Topics: Brimonidine Tartrate; Dermatologic Agents; Drug Eruptions; Erythema; Female; Humans; Middle Aged; Rosacea; Time Factors | 2015 |
Allergic contact dermatitis to topical brimonidine.
Topics: Administration, Cutaneous; Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Dermatitis, Allergic Contact; Drug Eruptions; Erythema; Facial Dermatoses; Humans; Male; Middle Aged | 2015 |
Topical brimonidine tartrate 0ยท33% gel effectively reduces the post-treatment erythema of daylight-activated photodynamic therapy.
Topics: Administration, Cutaneous; Adrenergic alpha-2 Receptor Agonists; Adult; Brimonidine Tartrate; Drug Eruptions; Erythema; Facial Dermatoses; Gels; Humans; Male; Photochemotherapy; Rosacea; Sunlight | 2016 |
The teardrop sign: a rare dermatological reaction to brimonidine.
Topics: Adrenergic alpha-Agonists; Adult; Antihypertensive Agents; Brimonidine Tartrate; Drug Eruptions; Facial Dermatoses; Humans; Male; Quinoxalines | 2000 |